Table 1.
Demographics, HCV status, HBsAg status and tumor characteristics of HCC cases
| ID | Age | Gender1 | Cirrhosis in nontumorous tissue | Grade | Anti-HCV | HBsAg |
|---|---|---|---|---|---|---|
| F003 | NA2 | NA | NA | NA | NA | NA |
| F004 | 67 | M | + | II | + | + |
| F005 | 47 | M | − | II | − | + |
| F006 | 70 | F | − | I | + | − |
| F007 | NA | NA | NA | NA | NA | NA |
| F008 | NA | M | NA | NA | NA | NA |
| F009 | 56 | M | − | NA | NA | + |
| F011 | NA | NA | NA | NA | NA | NA |
| F012 | 39 | M | − | III | + | + |
| F013 | 78 | M | + | II–III | − | + |
| F014 | 42 | M | − | III | − | + |
| F015 | NA | NA | NA | NA | NA | NA |
| F017 | 70 | F | − | II | + | − |
| F018 | 51 | M | − | II | − | + |
| F019 | 20 | M | − | I–II | − | + |
| F020 | NA | NA | NA | NA | NA | NA |
| F021 | 45 | M | − | II | − | + |
| F022 | 58 | M | + | I | + | − |
| F023 | 43 | M | − | II | − | + |
| F025 | 51 | M | − | II | + | − |
| F028 | 35 | F | − | III | NA | + |
| F029 | 49 | M | + | II | − | + |
| F030 | 37 | M | − | II | − | + |
| F032 | 50 | M | − | II | − | + |
| F033 | 48 | M | − | III | + | + |
| F034 | 44 | M | − | I–II | NA | + |
| F035 | 49 | M | + | III–IV | − | + |
| F036 | 62 | F | + | III | + | + |
| F038 | 62 | M | + | II | + | + |
| F039 | 69 | M | + | III | − | − |
| F040 | 76 | M | − | III | − | + |
| F042 | 40 | M | − | II | NA | + |
| F043 | 59 | F | + | III | − | + |
| F044 | NA | NA | NA | NA | NA | NA |
| F045 | 63 | M | + | II | − | + |
| F047 | 45 | M | + | II | − | + |
| F048 | 68 | M | + | II | NA | + |
| B115 | 45 | M | + | NA | − | + |
| B169 | 53 | M | NA | NA | − | − |
| D145 | 58 | M | NA | NA | + | NA |
M, male; F, female;
NA, data not avalable